nodes	percent_of_prediction	percent_of_DWPC	metapath
Gliclazide—VEGFA—chronic kidney failure	0.466	0.57	CbGaD
Gliclazide—CYP2C19—chronic kidney failure	0.226	0.276	CbGaD
Gliclazide—ALB—chronic kidney failure	0.125	0.153	CbGaD
Gliclazide—CYP2C9—cardial valve—chronic kidney failure	0.0108	0.267	CbGeAlD
Gliclazide—ABCC8—penis—chronic kidney failure	0.00785	0.194	CbGeAlD
Gliclazide—CYP2C19—urine—chronic kidney failure	0.00301	0.0744	CbGeAlD
Gliclazide—CYP2C9—urine—chronic kidney failure	0.00234	0.0577	CbGeAlD
Gliclazide—VEGFA—nephron tubule—chronic kidney failure	0.00213	0.0527	CbGeAlD
Gliclazide—VEGFA—urethra—chronic kidney failure	0.00191	0.0471	CbGeAlD
Gliclazide—VEGFA—cortex of kidney—chronic kidney failure	0.00183	0.0451	CbGeAlD
Gliclazide—CYP2C19—blood plasma—chronic kidney failure	0.00157	0.0388	CbGeAlD
Gliclazide—KCNJ11—cardiovascular system—chronic kidney failure	0.00137	0.0339	CbGeAlD
Gliclazide—Glyburide—CPT1A—chronic kidney failure	0.00136	0.208	CrCbGaD
Gliclazide—ABCC8—renal system—chronic kidney failure	0.00128	0.0316	CbGeAlD
Gliclazide—ABCC8—cardiovascular system—chronic kidney failure	0.00126	0.0312	CbGeAlD
Gliclazide—ABCC8—kidney—chronic kidney failure	0.00124	0.0305	CbGeAlD
Gliclazide—CYP2C9—blood plasma—chronic kidney failure	0.00122	0.0301	CbGeAlD
Gliclazide—Glyburide—ABCA1—chronic kidney failure	0.00103	0.158	CrCbGaD
Gliclazide—Tolbutamide—CYP2C18—chronic kidney failure	0.000802	0.123	CrCbGaD
Gliclazide—Glyburide—ABCC3—chronic kidney failure	0.000652	0.1	CrCbGaD
Gliclazide—CYP2C19—digestive system—chronic kidney failure	0.000604	0.0149	CbGeAlD
Gliclazide—CYP2C19—blood—chronic kidney failure	0.000576	0.0142	CbGeAlD
Gliclazide—CYP2C9—cardiovascular system—chronic kidney failure	0.000565	0.0139	CbGeAlD
Gliclazide—CYP2C9—digestive system—chronic kidney failure	0.000469	0.0116	CbGeAlD
Gliclazide—CYP2C9—blood—chronic kidney failure	0.000446	0.011	CbGeAlD
Gliclazide—Chlorpropamide—PTGS1—chronic kidney failure	0.000402	0.0616	CrCbGaD
Gliclazide—Chlorpropamide—CYP2C19—chronic kidney failure	0.000369	0.0565	CrCbGaD
Gliclazide—Tolbutamide—CYP2C19—chronic kidney failure	0.000359	0.0551	CrCbGaD
Gliclazide—Glyburide—ABCC2—chronic kidney failure	0.000358	0.0549	CrCbGaD
Gliclazide—Glipizide—CYP3A4—chronic kidney failure	0.000324	0.0497	CrCbGaD
Gliclazide—Glyburide—CYP2C19—chronic kidney failure	0.000249	0.0382	CrCbGaD
Gliclazide—Chlorpropamide—ABCB1—chronic kidney failure	0.000195	0.0299	CrCbGaD
Gliclazide—Glyburide—CYP3A4—chronic kidney failure	0.000158	0.0243	CrCbGaD
Gliclazide—Glyburide—ALB—chronic kidney failure	0.000138	0.0212	CrCbGaD
Gliclazide—Glyburide—ABCB1—chronic kidney failure	0.000132	0.0202	CrCbGaD
Gliclazide—VEGFA—Signaling Pathways—FGF23—chronic kidney failure	3.94e-05	0.00029	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	3.89e-05	0.000286	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CYP3A4—chronic kidney failure	3.84e-05	0.000282	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	3.81e-05	0.00028	CbGpPWpGaD
Gliclazide—ALB—Metabolism—FABP1—chronic kidney failure	3.79e-05	0.000279	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ABCA1—chronic kidney failure	3.77e-05	0.000278	CbGpPWpGaD
Gliclazide—ALB—Folate Metabolism—IL6—chronic kidney failure	3.76e-05	0.000277	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—SREBF2—chronic kidney failure	3.75e-05	0.000276	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CYP3A4—chronic kidney failure	3.72e-05	0.000274	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NPY—chronic kidney failure	3.71e-05	0.000273	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—TNF—chronic kidney failure	3.7e-05	0.000272	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—KRAS—chronic kidney failure	3.67e-05	0.00027	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ABCA1—chronic kidney failure	3.66e-05	0.000269	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—chronic kidney failure	3.62e-05	0.000266	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—F2—chronic kidney failure	3.61e-05	0.000266	CbGpPWpGaD
Gliclazide—CYP2C19—Biological oxidations—POMC—chronic kidney failure	3.61e-05	0.000265	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	3.61e-05	0.000265	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GATM—chronic kidney failure	3.59e-05	0.000264	CbGpPWpGaD
Gliclazide—ALB—Metabolism—AGXT—chronic kidney failure	3.59e-05	0.000264	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CRH—chronic kidney failure	3.58e-05	0.000263	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—OXT—chronic kidney failure	3.58e-05	0.000263	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	3.54e-05	0.000261	CbGpPWpGaD
Gliclazide—VEGFA—Cellular responses to stress—IL6—chronic kidney failure	3.51e-05	0.000258	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	3.51e-05	0.000258	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	3.51e-05	0.000258	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	3.47e-05	0.000255	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NCF1—chronic kidney failure	3.43e-05	0.000252	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—FABP1—chronic kidney failure	3.4e-05	0.00025	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—NFKB1—chronic kidney failure	3.39e-05	0.000249	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NPS—chronic kidney failure	3.39e-05	0.000249	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—DRD1—chronic kidney failure	3.33e-05	0.000245	CbGpPWpGaD
Gliclazide—CYP2C9—Biological oxidations—POMC—chronic kidney failure	3.29e-05	0.000242	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ACAT1—chronic kidney failure	3.29e-05	0.000242	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	3.25e-05	0.000239	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	3.24e-05	0.000238	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—AGXT—chronic kidney failure	3.23e-05	0.000237	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GATM—chronic kidney failure	3.23e-05	0.000237	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CYBA—chronic kidney failure	3.22e-05	0.000237	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	3.21e-05	0.000236	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CAT—chronic kidney failure	3.19e-05	0.000235	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—IGF1—chronic kidney failure	3.16e-05	0.000233	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	3.15e-05	0.000232	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	3.15e-05	0.000232	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ABCB1—chronic kidney failure	3.11e-05	0.000229	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—FABP1—chronic kidney failure	3.1e-05	0.000228	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CAT—chronic kidney failure	3.1e-05	0.000228	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—NOS1—chronic kidney failure	3.09e-05	0.000227	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	3.07e-05	0.000226	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MLXIPL—chronic kidney failure	3.06e-05	0.000225	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ABCB1—chronic kidney failure	3.01e-05	0.000222	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic kidney failure	3.01e-05	0.000221	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	3e-05	0.000221	CbGpPWpGaD
Gliclazide—ALB—Selenium Micronutrient Network—IL6—chronic kidney failure	2.99e-05	0.00022	CbGpPWpGaD
Gliclazide—VEGFA—Axon guidance—IL6—chronic kidney failure	2.98e-05	0.000219	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—LPL—chronic kidney failure	2.96e-05	0.000218	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ACAT1—chronic kidney failure	2.95e-05	0.000217	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	2.95e-05	0.000217	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—AGXT—chronic kidney failure	2.94e-05	0.000216	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GATM—chronic kidney failure	2.94e-05	0.000216	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	2.91e-05	0.000214	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	2.88e-05	0.000212	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	2.88e-05	0.000212	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	2.88e-05	0.000212	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—LPL—chronic kidney failure	2.87e-05	0.000211	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—CYP1A1—chronic kidney failure	2.86e-05	0.00021	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	2.83e-05	0.000208	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—HBEGF—chronic kidney failure	2.83e-05	0.000208	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TGFB1—chronic kidney failure	2.82e-05	0.000208	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SLC22A2—chronic kidney failure	2.8e-05	0.000206	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—CYP1A1—chronic kidney failure	2.77e-05	0.000204	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—TGFB1—chronic kidney failure	2.77e-05	0.000204	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	2.75e-05	0.000202	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MLXIPL—chronic kidney failure	2.74e-05	0.000202	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	2.73e-05	0.000201	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	2.69e-05	0.000198	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ACAT1—chronic kidney failure	2.69e-05	0.000198	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—MTHFR—chronic kidney failure	2.67e-05	0.000196	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	2.66e-05	0.000195	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—TNF—chronic kidney failure	2.64e-05	0.000194	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	2.63e-05	0.000193	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—KRAS—chronic kidney failure	2.62e-05	0.000192	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PPARA—chronic kidney failure	2.62e-05	0.000192	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ABCG1—chronic kidney failure	2.6e-05	0.000191	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—MTHFR—chronic kidney failure	2.59e-05	0.00019	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	2.58e-05	0.00019	CbGpPWpGaD
Gliclazide—VEGFA—Hemostasis—KRAS—chronic kidney failure	2.57e-05	0.000189	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PIP5K1B—chronic kidney failure	2.54e-05	0.000187	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PPARA—chronic kidney failure	2.54e-05	0.000187	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SLC22A2—chronic kidney failure	2.51e-05	0.000185	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	2.51e-05	0.000185	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MLXIPL—chronic kidney failure	2.5e-05	0.000184	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ARG2—chronic kidney failure	2.49e-05	0.000183	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	2.46e-05	0.000181	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	2.45e-05	0.00018	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—AVP—chronic kidney failure	2.45e-05	0.00018	CbGpPWpGaD
Gliclazide—ALB—Metabolism—LCAT—chronic kidney failure	2.44e-05	0.00018	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ABCG1—chronic kidney failure	2.33e-05	0.000172	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—EDN1—chronic kidney failure	2.33e-05	0.000172	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCL5—chronic kidney failure	2.31e-05	0.00017	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SLC22A2—chronic kidney failure	2.29e-05	0.000168	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PIP5K1B—chronic kidney failure	2.28e-05	0.000168	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—LPL—chronic kidney failure	2.26e-05	0.000166	CbGpPWpGaD
Gliclazide—ALB—Metabolism—DDC—chronic kidney failure	2.24e-05	0.000165	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ARG2—chronic kidney failure	2.24e-05	0.000165	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	2.24e-05	0.000165	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—AVP—chronic kidney failure	2.21e-05	0.000163	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—LCAT—chronic kidney failure	2.19e-05	0.000161	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PRKAG2—chronic kidney failure	2.18e-05	0.00016	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PRKD1—chronic kidney failure	2.18e-05	0.00016	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP2B6—chronic kidney failure	2.18e-05	0.00016	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	2.14e-05	0.000158	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NGF—chronic kidney failure	2.14e-05	0.000158	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—ABCB1—chronic kidney failure	2.14e-05	0.000157	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—POMC—chronic kidney failure	2.13e-05	0.000157	CbGpPWpGaD
Gliclazide—VEGFA—Developmental Biology—IL6—chronic kidney failure	2.13e-05	0.000157	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ABCG1—chronic kidney failure	2.13e-05	0.000156	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCR5—chronic kidney failure	2.08e-05	0.000153	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PIP5K1B—chronic kidney failure	2.08e-05	0.000153	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	2.07e-05	0.000152	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—POMC—chronic kidney failure	2.07e-05	0.000152	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic kidney failure	2.07e-05	0.000152	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ARG2—chronic kidney failure	2.04e-05	0.00015	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SREBF2—chronic kidney failure	2.04e-05	0.00015	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—DDC—chronic kidney failure	2.01e-05	0.000148	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—PLAU—chronic kidney failure	2e-05	0.000147	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—LCAT—chronic kidney failure	2e-05	0.000147	CbGpPWpGaD
Gliclazide—ALB—Metabolism—GCKR—chronic kidney failure	1.97e-05	0.000145	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ABCC3—chronic kidney failure	1.97e-05	0.000145	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PRKD1—chronic kidney failure	1.96e-05	0.000144	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PRKAG2—chronic kidney failure	1.96e-05	0.000144	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP2B6—chronic kidney failure	1.96e-05	0.000144	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—ALB—chronic kidney failure	1.94e-05	0.000143	CbGpPWpGaD
Gliclazide—ALB—Metabolism—LPIN1—chronic kidney failure	1.93e-05	0.000142	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	1.92e-05	0.000142	CbGpPWpGaD
Gliclazide—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic kidney failure	1.9e-05	0.00014	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	1.89e-05	0.000139	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP2C18—chronic kidney failure	1.89e-05	0.000139	CbGpPWpGaD
Gliclazide—ALB—Metabolism—LRP2—chronic kidney failure	1.89e-05	0.000139	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—ALB—chronic kidney failure	1.89e-05	0.000139	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—F2—chronic kidney failure	1.86e-05	0.000137	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—NOS3—chronic kidney failure	1.86e-05	0.000137	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	1.86e-05	0.000137	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—DDC—chronic kidney failure	1.84e-05	0.000135	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SREBF2—chronic kidney failure	1.83e-05	0.000135	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—NOS3—chronic kidney failure	1.8e-05	0.000133	CbGpPWpGaD
Gliclazide—ALB—Transmembrane transport of small molecules—PPARA—chronic kidney failure	1.8e-05	0.000132	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—F2—chronic kidney failure	1.79e-05	0.000132	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PRKAG2—chronic kidney failure	1.78e-05	0.000131	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PRKD1—chronic kidney failure	1.78e-05	0.000131	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP2B6—chronic kidney failure	1.78e-05	0.000131	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ABCC3—chronic kidney failure	1.77e-05	0.00013	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—GCKR—chronic kidney failure	1.77e-05	0.00013	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	1.75e-05	0.000129	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—LPIN1—chronic kidney failure	1.73e-05	0.000127	CbGpPWpGaD
Gliclazide—ABCC8—Metabolism—PTGS2—chronic kidney failure	1.7e-05	0.000125	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	1.7e-05	0.000125	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—LRP2—chronic kidney failure	1.7e-05	0.000125	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP2C18—chronic kidney failure	1.7e-05	0.000125	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	1.69e-05	0.000125	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IRS1—chronic kidney failure	1.69e-05	0.000124	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SREBF2—chronic kidney failure	1.67e-05	0.000123	CbGpPWpGaD
Gliclazide—KCNJ11—Metabolism—PTGS2—chronic kidney failure	1.65e-05	0.000121	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—IGF1—chronic kidney failure	1.63e-05	0.00012	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—POMC—chronic kidney failure	1.63e-05	0.00012	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ABCC3—chronic kidney failure	1.61e-05	0.000119	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—GCKR—chronic kidney failure	1.61e-05	0.000119	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CPT1A—chronic kidney failure	1.61e-05	0.000118	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—CCL2—chronic kidney failure	1.59e-05	0.000117	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—LPIN1—chronic kidney failure	1.58e-05	0.000116	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IGF1—chronic kidney failure	1.57e-05	0.000115	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP2C19—chronic kidney failure	1.56e-05	0.000115	CbGpPWpGaD
Gliclazide—ALB—Metabolism—LIPC—chronic kidney failure	1.56e-05	0.000115	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	1.55e-05	0.000114	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—SERPINE1—chronic kidney failure	1.55e-05	0.000114	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—LRP2—chronic kidney failure	1.55e-05	0.000114	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP2C18—chronic kidney failure	1.55e-05	0.000114	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	1.54e-05	0.000114	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—SERPINE1—chronic kidney failure	1.49e-05	0.000109	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—NOS3—chronic kidney failure	1.48e-05	0.000109	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SCARB1—chronic kidney failure	1.45e-05	0.000106	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CPT1A—chronic kidney failure	1.44e-05	0.000106	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTGS1—chronic kidney failure	1.43e-05	0.000105	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NOS3—chronic kidney failure	1.42e-05	0.000105	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—LIPC—chronic kidney failure	1.4e-05	0.000103	CbGpPWpGaD
Gliclazide—ALB—Metabolism—SREBF1—chronic kidney failure	1.4e-05	0.000103	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	1.39e-05	0.000102	CbGpPWpGaD
Gliclazide—ALB—Metabolism—HMGCR—chronic kidney failure	1.37e-05	0.0001	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—RELA—chronic kidney failure	1.34e-05	9.84e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—FASN—chronic kidney failure	1.34e-05	9.83e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CPT1A—chronic kidney failure	1.31e-05	9.67e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SCARB1—chronic kidney failure	1.3e-05	9.55e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTGS1—chronic kidney failure	1.28e-05	9.45e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—LIPC—chronic kidney failure	1.28e-05	9.42e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP2C19—chronic kidney failure	1.28e-05	9.42e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	1.26e-05	9.3e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	1.26e-05	9.29e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—SREBF1—chronic kidney failure	1.26e-05	9.27e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP3A4—chronic kidney failure	1.24e-05	9.1e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	1.23e-05	9.06e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—HMGCR—chronic kidney failure	1.23e-05	9.02e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ABCA1—chronic kidney failure	1.22e-05	8.95e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—FASN—chronic kidney failure	1.2e-05	8.82e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SCARB1—chronic kidney failure	1.18e-05	8.7e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTGS1—chronic kidney failure	1.17e-05	8.62e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	1.15e-05	8.48e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—SREBF1—chronic kidney failure	1.15e-05	8.45e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—NFKB1—chronic kidney failure	1.13e-05	8.3e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—HMGCR—chronic kidney failure	1.12e-05	8.22e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP3A4—chronic kidney failure	1.11e-05	8.17e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	1.11e-05	8.13e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—FASN—chronic kidney failure	1.09e-05	8.04e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ABCA1—chronic kidney failure	1.09e-05	8.04e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—VEGFA—chronic kidney failure	1.07e-05	7.84e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CAT—chronic kidney failure	1.03e-05	7.58e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP3A4—chronic kidney failure	1.01e-05	7.45e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	1.01e-05	7.41e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—ABCB1—chronic kidney failure	1e-05	7.37e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ABCA1—chronic kidney failure	9.96e-06	7.33e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—TGFB1—chronic kidney failure	9.78e-06	7.19e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—LPL—chronic kidney failure	9.55e-06	7.02e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—TGFB1—chronic kidney failure	9.39e-06	6.91e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CAT—chronic kidney failure	9.25e-06	6.8e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—CYP1A1—chronic kidney failure	9.22e-06	6.78e-05	CbGpPWpGaD
Gliclazide—ALB—Hemostasis—KRAS—chronic kidney failure	9.06e-06	6.66e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ABCB1—chronic kidney failure	9e-06	6.62e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—KRAS—chronic kidney failure	8.7e-06	6.4e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—MTHFR—chronic kidney failure	8.6e-06	6.32e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—LPL—chronic kidney failure	8.57e-06	6.31e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PPARA—chronic kidney failure	8.43e-06	6.2e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CAT—chronic kidney failure	8.43e-06	6.2e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—CYP1A1—chronic kidney failure	8.28e-06	6.09e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ABCB1—chronic kidney failure	8.2e-06	6.03e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—LPL—chronic kidney failure	7.82e-06	5.75e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—MTHFR—chronic kidney failure	7.72e-06	5.68e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PPARA—chronic kidney failure	7.57e-06	5.57e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—CYP1A1—chronic kidney failure	7.55e-06	5.55e-05	CbGpPWpGaD
Gliclazide—VEGFA—Signaling Pathways—IL6—chronic kidney failure	7.08e-06	5.21e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—MTHFR—chronic kidney failure	7.04e-06	5.18e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PPARA—chronic kidney failure	6.9e-06	5.08e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—POMC—chronic kidney failure	6.88e-06	5.06e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—POMC—chronic kidney failure	6.17e-06	4.54e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—NOS3—chronic kidney failure	6e-06	4.41e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—POMC—chronic kidney failure	5.63e-06	4.14e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—ALB—chronic kidney failure	5.63e-06	4.14e-05	CbGpPWpGaD
Gliclazide—ALB—Metabolism—PTGS2—chronic kidney failure	5.48e-06	4.03e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—NOS3—chronic kidney failure	5.38e-06	3.96e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—ALB—chronic kidney failure	5.13e-06	3.77e-05	CbGpPWpGaD
Gliclazide—CYP2C19—Metabolism—PTGS2—chronic kidney failure	4.92e-06	3.62e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—NOS3—chronic kidney failure	4.91e-06	3.61e-05	CbGpPWpGaD
Gliclazide—CYP2C9—Metabolism—PTGS2—chronic kidney failure	4.49e-06	3.3e-05	CbGpPWpGaD
